busulfan and mesna
busulfan has been researched along with mesna in 9 studies
Research
Studies (9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blacklock, HA; Brenner, MK; Ganczakowski, M; Hancock, JF; Hopewell, JP; Patterson, J; Pattinson, JK; Prentice, HG; Thomas, AE | 1 |
| Crowther, D; Ghielmini, M; Morgenstern, GR; Pettengell, R; Radford, JA; Scheid, C; Stern, PL | 1 |
| Boyett, J; Brenner, M; Heslop, HE; Ihle, J; Krance, R; Mahmoud, H; Moen, RC; Ribeiro, R; Roberts, WM; Santana, V | 1 |
| Machaczka, M; Piatkowska-Jakubas, B; Rucińska, M; Skotnicki, AB; Załuska, A | 1 |
| Hattori, K; Hotta, T; Inoue, H; Kato, S; Kawada, H; Kishi, K; Matsumoto, M; Ogawa, Y; Ohmachi, K; Shimizu, T; Tsuboi, K; Watanabe, S; Yabe, H; Yabe, M; Yasuda, Y; Yoshiba, F | 1 |
Reviews
1 review(s) available for busulfan and mesna
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
8 other study(ies) available for busulfan and mesna
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cystitis; Female; Hematuria; Hemorrhage; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mesna; Middle Aged; Risk Factors | 1987 |
Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukapheresis; Lymphocyte Count; Lymphocyte Subsets; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Mesna; Middle Aged; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Treatment Outcome; Vincristine | 1995 |
Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission.
Topics: Acute Disease; Adolescent; Base Sequence; Biomarkers; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cell Separation; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Resistance; Evaluation Studies as Topic; Genetic Markers; Genetic Vectors; Hematopoietic Stem Cells; Humans; Immunologic Factors; Infant; Informed Consent; Interleukin-2; Kanamycin Kinase; Leukemia, Myeloid; Mesna; Molecular Sequence Data; Phosphotransferases (Alcohol Group Acceptor); Recombinant Fusion Proteins; Remission Induction; Research Design; Retroviridae; Safety; Transplantation, Autologous | 1994 |
[Hemorrhagic cystitis related to the high-dose conditioning therapy in a bone marrow recipient].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Hematuria; Humans; Leukemia, Lymphoid; Male; Mesna; Premedication | 2001 |
Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.
Topics: Adolescent; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cystitis; Drug Synergism; Female; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Incidence; Male; Mesna; Multivariate Analysis; Retrospective Studies; Risk Factors; Therapeutic Irrigation; Transplantation, Homologous | 2003 |